<VariationArchive VariationID="1299703" VariationName="NM_032575.3(GLIS2):c.570_584del (p.Asn190_Val194del)" VariationType="Deletion" Accession="VCV001299703" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-11" DateCreated="2021-10-16" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1289756" VariationID="1299703">
      <GeneList>
        <Gene Symbol="GLIS2" FullName="GLIS family zinc finger 2" GeneID="84662" HGNC_ID="HGNC:29450" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="4314761" stop="4339595" display_start="4314761" display_stop="4339595" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187608.1" start="15125" stop="39959" display_start="15125" display_stop="39959" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="4382224" stop="4389597" display_start="4382224" display_stop="4389597" Strand="+" />
          </Location>
          <OMIM>608539</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032575.3(GLIS2):c.570_584del (p.Asn190_Val194del)</Name>
      <CanonicalSPDI>NC_000016.10:4335096:ACCATGTCAACGATTACCATGTCAA:ACCATGTCAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="4335097" stop="4335111" display_start="4335097" display_stop="4335111" variantLength="15" positionVCF="4335096" referenceAlleleVCF="GACCATGTCAACGATT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="4385098" stop="4385112" display_start="4385098" display_stop="4385112" variantLength="15" positionVCF="4385097" referenceAlleleVCF="GACCATGTCAACGATT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.4335107_4335121del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.4335107_4335121del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.4385108_4385122del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.4385108_4385122del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016391.2" sequenceAccession="NG_016391" sequenceVersion="2" change="g.25347_25361del">
            <Expression>NG_016391.2:g.25347_25361del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318918.2" sequenceAccession="NM_001318918" sequenceVersion="2" change="c.570_584del">
            <Expression>NM_001318918.2:c.570_584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305847.1" sequenceAccession="NP_001305847" sequenceVersion="1" change="p.Asn190_Val194del">
            <Expression>NP_001305847.1:p.Asn190_Val194del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032575.3" sequenceAccession="NM_032575" sequenceVersion="3" change="c.570_584del" MANESelect="true">
            <Expression>NM_032575.3:c.570_584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_115964.2" sequenceAccession="NP_115964" sequenceVersion="2" change="p.Asn190_Val194del">
            <Expression>NP_115964.2:p.Asn190_Val194del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032575.3" sequenceAccession="NM_032575" sequenceVersion="3" change="c.560_574del" MANESelect="true">
            <Expression>NM_032575.3:c.560_574del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032575.3" sequenceAccession="NM_032575" sequenceVersion="3" change="c.560_574delACCATGTCAACGATT" MANESelect="true">
            <Expression>NM_032575.3:c.560_574delACCATGTCAACGATT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608539.0003" DB="OMIM" />
        <XRef Type="rs" ID="2141132961" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein loss of function">
        <XRef ID="0043" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032575.3(GLIS2):c.570_584del (p.Asn190_Val194del) AND Nephronophthisis 7" Accession="RCV001730163" Version="1">
        <ClassifiedConditionList TraitSetID="569">
          <ClassifiedCondition DB="MedGen" ID="C1969092">Nephronophthisis 7</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-10-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_032575.3(GLIS2):c.570_584del (p.Asn190_Val194del) AND not provided" Accession="RCV003882737" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-02-23" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-23" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-10-16" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">34917135</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-03-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2024-03-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="569" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5621" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 7</ElementValue>
                <XRef ID="315139" DB="GeneTests" />
                <XRef ID="MONDO:0012680" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP7</ElementValue>
                <XRef Type="MIM" ID="611498" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1969092" DB="MedGen" />
              <XRef ID="MONDO:0012680" DB="MONDO" />
              <XRef Type="MIM" ID="611498" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3867930" SubmissionDate="2021-10-12" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey="SUB10508238" submittedAssembly="GRCh38" title="SUB10508238" />
        <ClinVarAccession Accession="SCV001977015" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Sayer Lab, Translational and Clinical Research Institute, Newcastle Unversity" OrgID="507949" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A novel homozygous in-frame deletion (NM_032575.3: c.560_574delACCATGTCAACGATT, p.H188_Y192del) in GLIS2 gene in a consanguineous family. The five amino acid deletion disrupts the alpha-helix of GLIS2 zinc-finger motif with predicted misfolding of the protein leading to its predicted pathogenicity.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Omani</Ethnicity>
              <GeographicOrigin>Oman</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-10-03" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000090" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0003774" />
              </Trait>
            </TraitSet>
            <Comment>Homozygous allele segregating from both parents</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLIS2">
              <Name>GLIS family zinc finger 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_032575.3:exon 4</GeneLocation>
          </Location>
          <FunctionalConsequence Value="protein loss of function">
            <XRef DB="Variation Ontology" ID="0043" URL="http://purl.obolibrary.org/obo/VariO_0043" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032575.3:c.560_574delACCATGTCAACGATT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611498" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10508238</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8652898" SubmissionDate="2024-02-23" DateLastUpdated="2024-03-10" DateCreated="2024-03-05">
        <ClinVarSubmissionID localKey="608539.0003_VARIANT OF UNKNOWN SIGNIFICANCE" title="GLIS2, 15-BP DEL, NT560_VARIANT OF UNKNOWN SIGNIFICANCE" />
        <ClinVarAccession Accession="SCV004697485" DateUpdated="2024-03-10" DateCreated="2024-03-05" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">This variant is classified as a variant of unknown significance because its contribution to nephronophthisis (see NPHP7; 611498) has not been confirmed.</Attribute>
              <XRef DB="OMIM" ID="611498" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In an 11-year-old girl, born of consanguineous Omani parents, with isolated nephronophthisis (see NPHP7; 611498), Al Alawi et al. (2021) identified a homozygous 15-bp in-frame deletion (c.560_574del, NM_032575.3) in exon 4 of the GLIS2 gene, predicted to result in the deletion of 5 residues (His188_Tyr192del) that are evolutionarily conserved and close to the zinc-finger C2H2-type DNA-binding domain. The authors described the mutation as c.562_576del in Figure 1 of the report. The variant, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was present in the heterozygous state in the unaffected parents. The variant was not present in public databases, including gnomAD. Functional studies of the variant were not performed, but molecular modeling suggested that it could cause protein misfolding or a loss of function due to altered DNA-binding capacity. According to ACMG guidelines, Al Alawi et al. (2021) classified the c.560_574del allele as a variant of uncertain significance. The affected girl presented at 9 years of age with right hip injury and was found to be hypertensive with advanced chronic kidney disease and evidence of renal failure. Kidney ultrasound showed normal-sized but echogenic kidneys with loss of corticomedullary differentiation. Urinalysis did not show significant proteinuria. Renal biopsy showed tubular injury, dilated tubules, duplication of tubular basement membranes, tubulointerstitial nephritis, interstitial fibrosis, and tubular atrophy, consistent with NPHP. Immunofluorescence studies were negative. The kidney disease was progressive, and she reached end-stage renal disease by 10 years of age.</Attribute>
              <Citation>
                <ID Source="PubMed">34917135</ID>
              </Citation>
              <XRef DB="OMIM" ID="611498" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLIS2" />
          </GeneList>
          <Name>GLIS2, 15-BP DEL, NT560</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15-BP DEL, NT560</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608539.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VARIANT OF UNKNOWN SIGNIFICANCE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3867930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003774" MappingRef="HP">
        <MedGen CUI="C2316810" Name="Stage 5 chronic kidney disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3867930" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000090" MappingRef="HP">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3867930" TraitType="Disease" MappingType="XRef" MappingValue="611498" MappingRef="OMIM">
        <MedGen CUI="C1969092" Name="Nephronophthisis 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8652898" TraitType="Disease" MappingType="Name" MappingValue="VARIANT OF UNKNOWN SIGNIFICANCE" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

